Recent company announcements highlight progress in Q2 FY2026 results and advancement of scalable Sustainable Aviation Fuel (SAF) feedstock strategy through the SCO initiative. The company also completed Phase I PTU process design for Project Verdant and is advancing development and financing initiatives.

• UMeWorld reported Q2 FY2026 results and advanced its scalable SAF feedstock strategy through its SCO initiative [N1].
• UMeWorld completed Phase I PTU process design for Project Verdant and is advancing development and financing initiatives [N1].

UMeWorld's focus on DAGola™ functional cooking oils taps into growing consumer interest in health and wellness products. The company's online sales model allows for scalable customer acquisition and brand development. Progress in biofuel and Sustainable Aviation Fuel (SAF) feedstock initiatives, including completion of Phase I PTU process design and advancing financing efforts, could open new growth avenues. The leadership's experience in capital formation and strategic partnerships supports potential expansion and operational scaling.

UMeWorld faces significant risks from its dependence on a single specialized DAG oil supplier and a limited number of distributors, which could disrupt supply or revenue streams. The company has a history of operating losses and working capital deficiencies, with liquidity ratios below 1.0, indicating financial constraints. Its early-stage biofuel initiatives have yet to generate revenue and may require substantial capital. The company's reliance on outsourced services may expose it to operational risks. Competitive pressures from established food and wellness companies may limit market penetration and growth.

UMeWorld's moat is limited given its early-stage commercial operations, reliance on a single specialized supplier for DAG oil, and concentration of revenue from a small number of distributors. The company's focus on functional cooking oils with metabolic benefits positions it in a niche wellness market, but it faces competition from established food and consumer product companies. Its outsourced operational model provides cost flexibility but may limit control over supply chain and fulfillment. The company's ongoing development of biofuel and SAF feedstock initiatives could diversify its business in the future, but these remain nascent and unproven.

• Supplier Concentration Risk: UMeWorld depends on a single specialized DAG oil supplier in China, which accounted for a substantial majority of cost of sales. Disruptions or pricing changes could adversely affect production and margins [S2].
• Customer Concentration Risk: A substantial portion of revenue is derived from one or two distributors in China. Loss or reduction in orders from these distributors could materially impact revenues and cash flows [S2].
• Operational Dependence on Third Parties: The company relies on third-party manufacturers, co-packers, and logistics providers. Service interruptions or cost increases at these providers could disrupt fulfillment and increase operating costs [S2].
• Financial and Liquidity Risks: UMeWorld has incurred recurring losses and reported working capital deficiencies with a current ratio below 1.0 and a low cash ratio, indicating potential liquidity constraints [S2].
• Early-Stage Business and Market Risks: The company is in early stages of commercializing its DAGola™ brand with limited brand awareness and modest distribution reach. Biofuel and SAF initiatives are nascent and unproven [S1].
• Competitive and Regulatory Risks: UMeWorld faces competition from established food, wellness, and consumer product companies. Regulatory developments affecting food products and nutritional labeling could impact operations [S1].

• UMeWorld Inc. is a holding company with no substantive operations of its own, conducting business through a wholly owned U.S. subsidiary [S1].
• Primary business focus is development, marketing, and sale of DAG (diacylglycerol) cooking oils under the DAGola™ brand, positioned in the functional and wellness cooking oil market [S1].
• Revenue is primarily generated through online sales of DAGola™ cooking oil products [S1].
• The company has discontinued its Cellugizer sports-supplement product line and fully wrote off related inventory [S1].
• Biofuel and Sustainable Aviation Fuel (SAF) feedstock initiatives are in early planning and feasibility stages, with no revenue generated from these activities yet [S1].
• The company completed redomiciliation from British Virgin Islands to Delaware effective October 2, 2025 [S1].
• UMeWorld has wholly owned subsidiaries in Hong Kong and Mainland China, which are non-operating or engaged in preliminary activities [S1].
• The company depends on a specialized DAG oil supplier in China, with a single supplier accounting for a substantial majority of cost of sales in recent quarters, creating supply concentration risk [S2].
• A substantial portion of revenue is derived from one or two distributors in China, creating customer concentration risk [S2].
• The company relies on third-party manufacturers, co-packers, and logistics providers, with potential risks from service interruptions or cost increases [S2].
• As of June 30, 2026, the company reported revenue of $540,359 and a net loss of $92,885 for the quarter [S2].
• Liquidity ratios as of June 30, 2026 show a current ratio of 0.83 and a cash ratio of 0.07, indicating working capital deficiency [S2].
• Cash and cash equivalents were $121,809 as of September 30, 2024 [S1].
• The company has incurred recurring losses since inception and expects operating losses to continue for the foreseeable future [S1].
• The CEO, Michael M. Lee, is the founder and has led the company through multiple business transitions, currently focusing on health, wellness, and sustainable energy [S1].
• The company operates with one full-time employee (the CEO) and outsources other functions to independent contractors and third-party service providers [S1].
• The company has never declared or paid dividends and intends to retain earnings to finance operations and expansion [S1].
• The company’s ordinary shares trade over-the-counter under the symbol UMEWF [S1].
• Recent news includes company announcements on Q2 FY2026 results and progress on scalable SAF feedstock strategy, and completion of Phase I PTU process design for Project Verdant with development and financing initiatives [N1].